NeurotraumaVERIFIED PUBLICATION2023

Impact of inflammatory cell ratio, biomarkers, activated partial thromboplastin time and prothrombin time on chronic subdural haematoma severity and outcome

Authors: Julius Mautin Vitowanu, Collaborators

Journal: Clinical Neurological Research

Plain-Language Summary

Why This Research Matters

Chronic subdural hematomas are not merely mechanical collections of blood; they involve active inflammatory membranes. Identifying blood biomarkers helps surgeons predict which patients have a higher risk of recurrence before or after surgery.

Research investigating how specific blood markers and clotting indicators relate to how severe a chronic brain bleed is and how well patients recover after surgical evacuation.

Scientific Abstract

Study Abstract

Chronic subdural hematoma (CSDH) is increasingly prevalent in the aging population. This investigation evaluated systemic inflammatory markers (including neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios) alongside coagulation indices (aPTT and PT) to determine their prognostic significance in clinical severity and postoperative recurrence.

Bibliographic Reference

Julius Mautin Vitowanu, Collaborators (2023). "Impact of inflammatory cell ratio, biomarkers, activated partial thromboplastin time and prothrombin time on chronic subdural haematoma severity and outcome". Clinical Neurological Research.

Clinical Linkage

Related Clinical Care

Research insights from this study directly inform Dr. Vitowanu’s clinical evaluations and patient counsel.